Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides.
about
NKT cells stimulated by long fatty acyl chain sulfatides significantly reduce the incidence of type 1 diabetes in nonobese diabetic mice [corrected]Calreticulin controls the rate of assembly of CD1d molecules in the endoplasmic reticulumStructure and function of a potent agonist for the semi-invariant natural killer T cell receptorSynthetic glycolipid activators of natural killer T cells as immunotherapeutic agentsCD1d- and MR1-Restricted T Cells in SepsisTurned on by danger: activation of CD1d-restricted invariant natural killer T cellsThe regulatory role of invariant NKT cells in tumor immunityMechanisms for Glycolipid Antigen-Driven Cytokine Polarization by V 14i NKT CellsA Molecular Basis for the Exquisite CD1d-Restricted Antigen Specificity and Functional Responses of Natural Killer T CellsA semi-invariant Vα10+ T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition propertiesHuman and Mouse Type I Natural Killer T Cell Antigen Receptors Exhibit Different Fine Specificities for CD1d-Antigen ComplexNKT TCR Recognition of CD1d- -C-GalactosylceramideStructural Basis for the Recognition of C20:2-αGalCer by the Invariant Natural Killer T Cell Receptor-like Antibody L363Glycolipids that Elicit IFN-γ-Biased Responses from Natural Killer T CellsEnhanced TCR Footprint by a Novel Glycolipid Increases NKT-Dependent Tumor ProtectionIntravital imaging - dynamic insights into natural killer T cell biologyInvariant natural killer T cells and their ligands: focus on multiple sclerosisImproving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cellsAnalysis of the CD1 antigen presenting system in humanized SCID miceRaising the roof: the preferential pharmacological stimulation of Th1 and th2 responses mediated by NKT cells.Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramideDetermination of cellular lipids bound to human CD1d molecules.Recognition of lyso-phospholipids by human natural killer T lymphocytes.Stimulation of natural killer T cells by glycolipidsHeteroaromatic Moieties in the Sphingosine Backbone of α-Galactosylceramides for Noncovalent Interactions with CD1dReciprocal Crosstalk between Dendritic Cells and Natural Killer T Cells: Mechanisms and Therapeutic Potential.Lipid and glycolipid antigens of CD1d-restricted natural killer T cells.Α-galactosylceramide analogs with weak agonist activity for human iNKT cells define new candidate anti-inflammatory agentsThe stimulating adventure of KRN 7000.A rapid fluorescence-based assay for classification of iNKT cell activating glycolipids.Combinatorial synthesis of galactosyl-1,3,5-triazines as novel nucleoside analogues.Primary deficiency of microsomal triglyceride transfer protein in human abetalipoproteinemia is associated with loss of CD1 function.Cytokine dependent and independent iNKT cell activationNKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs.The effect of intracellular trafficking of CD1d on the formation of TCR repertoire of NKT cells.Activated iNKT cells promote memory CD8+ T cell differentiation during viral infectionDo CD1-restricted T cells contribute to antibody-mediated immunity against Mycobacterium tuberculosis?Direct incorporation of the NKT-cell activator α-galactosylceramide into a recombinant Listeria monocytogenes improves breast cancer vaccine efficacyMouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity.Diverse roles of non-diverse molecules: MHC class Ib molecules in host defense and control of autoimmunity
P2860
Q21134826-0BEACF62-33F7-445E-8497-1085269C94C1Q24634393-A96DEC5D-36F4-4B54-BE46-59AD283029CAQ24672186-762350CD-86D5-42B1-AFAC-D0622FB297B3Q26748456-EC6BFEE7-A9B1-43D3-8A88-A515EB1FFF57Q26796132-155213F9-CB58-455E-B229-4AFF175442D3Q26825059-BEDDC1FC-CFA1-43C5-BCB1-2DB28DC37F6EQ27023425-98464541-D5CF-467D-8847-6103321B63DCQ27658388-F7B67979-9016-49AB-B55A-907B1FB0991EQ27667168-6CBF105B-F6CB-493D-8D7F-F92A1B76B9C7Q27670418-EAAB97F6-8947-484A-8101-E26D489322CAQ27673493-04EC83EE-726A-4C97-8789-6651E80B2B19Q27674653-D1202883-88C8-4395-A28A-CE5666C4C72DQ27675769-622D9D85-B1E8-4360-91C2-F03A8CD03795Q27676395-57E9CD8A-93F6-4EC0-92C7-3B359ADFD5A8Q27679771-63CCEDF3-E2B4-4378-A6BE-37182D8254E4Q28081530-75B2AEE5-CE67-4524-BCCD-031E0066047FQ28083069-DDE0EAA8-B267-4A5B-924B-6579E8FEC573Q28543248-579C488C-6FC3-4099-B9CE-9FF960C721ECQ28743012-8D6E1D50-FD51-43EE-8F56-F7E19103BBD6Q30408873-870812B0-04AB-4A7E-85F0-9F69471F419FQ33389529-DB100FE0-BA9A-4FF2-B12F-CDBBE2EAE4BCQ33438880-99151F90-98E0-4F19-92B6-ACCEC276ADBBQ33512901-F938FCE8-1C5F-4914-9A77-18A905C159F5Q33599059-1E05F338-1EE4-4C31-9200-D4CEF7FF5B07Q33630528-B7723F22-60C2-4399-A661-7649A9AD6BA3Q33720359-B59FA22D-1FE7-4613-A075-5B70A4043629Q33724575-B1482917-1A2C-42C1-86D5-8DCCA3AD1796Q33778356-274A3712-A8E8-4E9E-8363-141910D1344FQ33843406-4491BE90-FCAD-4F18-8753-D0F0A6481FEBQ33852300-033F29FB-B2A6-4D58-819A-D3335C9B0C96Q34001538-7EA2FF89-F7B6-459E-9250-0E7002E67DD4Q34028751-8F8AFA20-BF8E-45C8-85D2-766CFE967E51Q34039891-CBD88382-0645-48CD-8590-CD18B244B957Q34078681-213CD395-1F0F-42B8-B57D-F1E13718589EQ34179888-E7C73FDC-2274-465A-8D99-4394BEA1C573Q34287659-1AD8A296-D36D-49E0-9C58-F3CAD1F1DB60Q34334259-63B3D38C-632A-4152-BE88-96B5171C0973Q34499626-E5A00AAC-24B0-46CA-B86A-F11E4955915DQ34519826-D99948D8-A1D6-4943-858E-D2665235B424Q34626935-3B242ACD-7718-4921-9388-8A286FC6E3A2
P2860
Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Modulation of CD1d-restricted ...... of alpha-galactosylceramides.
@ast
Modulation of CD1d-restricted ...... of alpha-galactosylceramides.
@en
type
label
Modulation of CD1d-restricted ...... of alpha-galactosylceramides.
@ast
Modulation of CD1d-restricted ...... of alpha-galactosylceramides.
@en
prefLabel
Modulation of CD1d-restricted ...... of alpha-galactosylceramides.
@ast
Modulation of CD1d-restricted ...... of alpha-galactosylceramides.
@en
P2093
P2860
P50
P356
P1476
Modulation of CD1d-restricted ...... of alpha-galactosylceramides.
@en
P2093
Alberto Molano
Claire Forestier
Karl O A Yu
Nagatoshi Fujiwara
Petr A Illarionov
Sachiko Miyake
Takashi Yamamura
Yves Dutronc
P2860
P304
P356
10.1073/PNAS.0407488102
P407
P577
2005-02-18T00:00:00Z